Aurora Cannabis (ACB) Competitors $3.91 -0.17 (-4.17%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$3.94 +0.03 (+0.66%) As of 06/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. BGM, TVTX, CVAC, AMPH, CALT, GPCR, ELVN, NAGE, AUPH, and WVEShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Qilian International Holding Group (BGM), Travere Therapeutics (TVTX), CureVac (CVAC), Amphastar Pharmaceuticals (AMPH), Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), Enliven Therapeutics (ELVN), Niagen Bioscience (NAGE), Aurinia Pharmaceuticals (AUPH), and Wave Life Sciences (WVE). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Its Competitors Qilian International Holding Group Travere Therapeutics CureVac Amphastar Pharmaceuticals Calliditas Therapeutics AB (publ) Structure Therapeutics Enliven Therapeutics Niagen Bioscience Aurinia Pharmaceuticals Wave Life Sciences BGM Group (NASDAQ:BGM) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the media refer more to BGM or ACB? In the previous week, Aurora Cannabis had 18 more articles in the media than BGM Group. MarketBeat recorded 18 mentions for Aurora Cannabis and 0 mentions for BGM Group. BGM Group's average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.21 indicating that BGM Group is being referred to more favorably in the media. Company Overall Sentiment BGM Group Neutral Aurora Cannabis Neutral Which has preferable earnings & valuation, BGM or ACB? Aurora Cannabis has higher revenue and earnings than BGM Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$25.10M50.82-$1.44MN/AN/AAurora Cannabis$246.72M0.89$1.63M$0.1135.55 Is BGM or ACB more profitable? Aurora Cannabis has a net margin of 1.32% compared to BGM Group's net margin of 0.00%. Aurora Cannabis' return on equity of 0.13% beat BGM Group's return on equity.Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A Aurora Cannabis 1.32%0.13%0.10% Do insiders & institutionals have more ownership in BGM or ACB? 47.6% of Aurora Cannabis shares are owned by institutional investors. 58.7% of BGM Group shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, BGM or ACB? BGM Group has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Does the MarketBeat Community believe in BGM or ACB? Aurora Cannabis received 384 more outperform votes than BGM Group when rated by MarketBeat users. CompanyUnderperformOutperformBGM GroupN/AN/AAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Do analysts recommend BGM or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 SummaryAurora Cannabis beats BGM Group on 12 of the 15 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$229.35M$10.21B$5.37B$8.54BDividend YieldN/A2.11%5.38%4.23%P/E Ratio35.5516.6125.7119.27Price / Sales0.8927.72393.46105.83Price / Cash6.6724.2125.4426.73Price / Book0.503.617.885.66Net Income$1.63M$235.13M$3.15B$248.36M7 Day Performance-33.50%-0.40%-0.70%0.66%1 Month Performance-28.91%-1.14%3.34%3.66%1 Year Performance-23.18%-15.27%41.38%14.80% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.2343 of 5 stars$3.91-4.2%N/A-23.2%$229.35M$246.72M35.551,073Earnings ReportBGMQilian International Holding GroupN/A$14.10+4.4%N/AN/A$1.37B$25.10M0.00298Positive NewsHigh Trading VolumeTVTXTravere Therapeutics2.5322 of 5 stars$14.68+1.2%$32.14+119.0%+98.2%$1.30B$273.53M-3.58460CVACCureVac4.5653 of 5 stars$5.52-0.9%$9.00+63.0%+65.3%$1.24B$523.70M10.04880AMPHAmphastar Pharmaceuticals4.2307 of 5 stars$25.98+0.6%$32.33+24.5%-39.0%$1.22B$730.66M8.661,620Positive NewsCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180GPCRStructure Therapeutics1.6646 of 5 stars$20.57-5.1%$76.50+271.9%-51.5%$1.18BN/A-27.80136News CoverageAnalyst ForecastELVNEnliven Therapeutics2.6805 of 5 stars$23.09+5.4%$39.60+71.5%-5.4%$1.13BN/A-12.1550Gap UpHigh Trading VolumeNAGENiagen Bioscience1.3964 of 5 stars$14.14+3.7%$19.50+37.9%N/A$1.11B$107.93M83.18120Analyst UpgradeAUPHAurinia Pharmaceuticals3.3001 of 5 stars$8.14-0.5%$11.50+41.3%+41.6%$1.10B$247.30M-54.26300Positive NewsWVEWave Life Sciences4.3606 of 5 stars$6.85-1.4%$20.50+199.3%+32.6%$1.06B$104.94M-6.17240News CoverageAnalyst Forecast Related Companies and Tools Related Companies Qilian International Holding Group Competitors Travere Therapeutics Competitors CureVac Competitors Amphastar Pharmaceuticals Competitors Calliditas Therapeutics AB (publ) Competitors Structure Therapeutics Competitors Enliven Therapeutics Competitors Niagen Bioscience Competitors Aurinia Pharmaceuticals Competitors Wave Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredHow high will gold surge? Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and de...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts